Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC.NUS · Entity 6223 | EVP, President of Global Sales | March 06, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NU SKIN ENTERPRISES, INC.
Report date March 06, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 160,170 |
Reported balance
After 2026-03-06 transaction · row 1
1 source rowRow 1 · 2026-03-06 · Grant · Acquired 47,059 · Balance 160,170 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 9, 2026 22:14 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 47,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-26-000040 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,170 Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:42 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 13,687 | $8.63 | $118,118.81 |
DisclosureSEC source: 0001021561-26-000030 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,111 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 1,534 | $8.36 | $12,824.24 |
DisclosureSEC source: 0001021561-26-000020 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,798 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 34,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-26-000010 · form4.xml · nonDerivative · entry 2 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,332 F2 · shares: On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 2,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-26-000010 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,832 F1 · shares: On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| March 05, 2025 Filed Mar 24, 2025 22:06 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | OtherClass A Common Stock | 48 | $7.44 | $357.12 |
DisclosureSEC source: 0001062993-25-006151 · form4.xml · nonDerivative · entry 4 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,922 F1 · shares: The Reporting Person received these shares pursuant to a dividend reinvestment by the Reporting Person's broker and without the Reporting Person's knowledge. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:48 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 51,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003804 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,749 Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 5,552 | $7.56 | $41,973.12 |
DisclosureSEC source: 0001062993-25-002892 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,002 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:40 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 1,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002559 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,554 F1 · shares: On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 12, 2025, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| December 11, 2024 Filed Mar 24, 2025 22:06 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | OtherClass A Common Stock | 47 | $7.62 | $358.14 |
DisclosureSEC source: 0001062993-25-006151 · form4.xml · nonDerivative · entry 3 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,874 F1 · shares: The Reporting Person received these shares pursuant to a dividend reinvestment by the Reporting Person's broker and without the Reporting Person's knowledge. Read SEC document |
| September 11, 2024 Filed Mar 24, 2025 22:06 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | OtherClass A Common Stock | 51 | $6.99 | $356.49 |
DisclosureSEC source: 0001062993-25-006151 · form4.xml · nonDerivative · entry 2 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,827 F1 · shares: The Reporting Person received these shares pursuant to a dividend reinvestment by the Reporting Person's broker and without the Reporting Person's knowledge. Read SEC document |
| June 12, 2024 Filed Mar 24, 2025 22:06 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | OtherClass A Common Stock | 27 | $13.13 | $354.51 |
DisclosureSEC source: 0001062993-25-006151 · form4.xml · nonDerivative · entry 1 Keisel Justin S · CIK 0002014791 · EVP, President of Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,776 F1 · shares: The Reporting Person received these shares pursuant to a dividend reinvestment by the Reporting Person's broker and without the Reporting Person's knowledge. F2 · balance_after: The number of shares reported in column 5 is the number of shares beneficially owned as of the date of this report and takes into account transactions reported on Form 4 since the dates of the transactions reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.